GeneMatrix Inc Capital Reinvestment Ratio
GeneMatrix Inc capital reinvestment ratio. GeneMatrix Inc (109820) has a Capital Reinvestment Ratio of 0.05x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩500.19 Million) in capital expenditures (₩23.65 Million). See free cash flow generation of GeneMatrix Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of GeneMatrix Inc (2020–2021)
Capital reinvestment ratio of GeneMatrix Inc from 2020 to 2021. This chart tracks GeneMatrix Inc's Capital Reinvestment Ratio across 2 annual periods. See GeneMatrix Inc (109820) financial flexibility to measure the company's free cash flow as a share of total liabilities.
GeneMatrix Inc Capital Reinvestment Ratio by Year (2020–2021)
GeneMatrix Inc capital reinvestment ratio by year from 2020 to 2021. For the full cash flow conversion analysis, see cash flow conversion of GeneMatrix Inc.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.08x | ₩3.37 Billion | ₩258.22 Million | ▼ -5.8% |
| 2020 | 0.08x | ₩4.51 Billion | ₩366.56 Million | — |